UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Persistence of HIV-1 Transmitted Drug Resistance Mutations

The Journal of infectious diseases, 2013-11, Vol.208 (9), p.1459-1463

2013

Volltextzugriff (PDF)

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom

HIV medicine, 2017-03, Vol.18 (3), p.204-213

2017

Volltextzugriff (PDF)

Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy

Clinical infectious diseases, 2009-05, Vol.48 (9), p.1296-1305

2009

Volltextzugriff (PDF)

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

Clinical infectious diseases, 2019-09, Vol.69 (7), p.1136-1143

2019

Volltextzugriff (PDF)

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3487-3494

2016

Volltextzugriff (PDF)

Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals

Journal of Virology, 2009-03, Vol.83 (6), p.2645-2654

2009

Volltextzugriff (PDF)

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.746-753

2019

Volltextzugriff (PDF)

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom

The Journal of infectious diseases, 2016-11, Vol.214 (9), p.1302-1308

2016

Volltextzugriff (PDF)

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1220-1236

2013

Volltextzugriff (PDF)

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation

HIV medicine, 2020-05, Vol.21 (5), p.309-321

2020

Volltextzugriff (PDF)

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2339-2343

2013

Volltextzugriff (PDF)

Evidence of a decline in transmitted HIV-1 drug resistance in the united Kingdom

AIDS (London), 2007-05, Vol.21 (8), p.1035-1039

Dunn, D

2007

Volltextzugriff (PDF)

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

BMJ (Online), 2012-08, Vol.345 (aug21 2), p.e5253-e5253

2012

Volltextzugriff (PDF)

The prevalence of darunavir―associated mutations in HIV―1―infected children in the UK

Antiviral therapy, 2012-01, Vol.17 (4), p.599-603

2012

Volltextzugriff (PDF)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance

BMC medical research methodology, 2012-03, Vol.12 (1), p.30-30, Article 30

2012

Volltextzugriff (PDF)

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

Antiviral therapy, 2010-01, Vol.15 (7), p.985-991

2010

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

ThemaHiv-1 - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Persistence of HIV-1 Transmitted Drug Resistance Mutations

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom

Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK

Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

Evidence of a decline in transmitted HIV-1 drug resistance in the united Kingdom

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

The prevalence of darunavir―associated mutations in HIV―1―infected children in the UK

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

Aktive Filter

Suchergebnisse filtern